WEBProducts. Learn more about our product portfolio and how we're prioritizing vaccines and specialty medicines to get ahead of disease together. Below you can find the full A-Z list of our products available in the United States.
WEBEvery day, our general medicines improve health and make life better for millions all over the world and our portfolio of more than 150 primary care products supplied in 112 countries worldwide. View our product areas
WEBHome | GSK US. Vaccines. People 50 and older are at increased risk for shingles – Protect your power. THRIVE@50+ empowers adults 50 years and older to learn about their risk for shingles.
WEBWith over 50 years in respiratory care, GSK is committed to helping patients breathe better by continuously redefining treatment for COPD and asthma. We are driven by our commitment to research and uniting innovative science and technology to help people with these respiratory conditions live more comfortably.
WEBProducts A-Z. Below you can find a full list of our products. Our vaccines and medicines are approved in individual countries for specific uses and the information we provide is governed by local regulation. Patients should always ask …
WEBGSK has the broadest vaccine platform technology portfolio in the industry. This enables us to select the most promising technology approach (or combinations of different platform technologies) to develop new vaccines not previously thought possible.
WEBGSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.
WEBOur specialty medicines is focused on four therapeutic areas: infectious diseases, HIV, respiratory/immunology and oncology. We’re leaders in infectious diseases and HIV innovation and we’re building our positions in immunology and oncology.